BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4801442)

  • 1. [Proceedings: Estrogen over or undersupply in hormonal contraception?].
    Schwartz U; Hammerstein J
    Arch Gynakol; 1973 Sep; 214(1):255-6. PubMed ID: 4801442
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oral contraceptives on human endometrium in culture.
    Csermely T; Hughes EC; Demers LM
    Am J Obstet Gynecol; 1971 Apr; 109(7):1066-72. PubMed ID: 4101599
    [No Abstract]   [Full Text] [Related]  

  • 3. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.
    Schwartz U; Hammerstein J
    Acta Endocrinol (Copenh); 1974 May; 76(1):159-71. PubMed ID: 4406579
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of various steroids on the vaginal histology in the rat.
    Jones RC; Edgren RA
    Fertil Steril; 1973 Apr; 24(4):284-91. PubMed ID: 4694503
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitors of ovulation as inhibitors of proliferation].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1973 Jan; 33(1):23-7. PubMed ID: 4119488
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic influence of oral contraceptives.
    Anberg A
    Acta Obstet Gynecol Scand; 1966; 45(S9):40. PubMed ID: 5958395
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver metabolism and contraceptive steroids.
    Brohult J; Westgren A
    Acta Obstet Gynecol Scand; 1966; 45(S9):38-9. PubMed ID: 5958394
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some effects of oral contraceptives on serum-lipid and lipoprotein levels.
    Wynn JW; Doar JW; Mills GL
    Lancet; 1966 Oct; 2(7466):720-3. PubMed ID: 4162056
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oral contraceptives on glucuronyl transferase.
    Hargreaves T; Piper RF; Cam J
    Nat New Biol; 1971 Nov; 234(47):110-1. PubMed ID: 5289221
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of some steroids in oral contraceptives on the cleavage of rabbit eggs in vitro.
    Daniel JC; Cowan ML
    J Endocrinol; 1966 Jun; 35(2):155-60. PubMed ID: 5950221
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women.
    McLeroy VJ; Schendel HE
    Am J Clin Nutr; 1973 Feb; 26(2):191-6. PubMed ID: 4122161
    [No Abstract]   [Full Text] [Related]  

  • 17. An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
    Moore DE; Kawagoe S; Davajan V; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1978 Feb; 130(4):482-6. PubMed ID: 204191
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):558-62. PubMed ID: 5779248
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the endometrium during oral hormonal contraception with ethinyl estradiol sulfonate and norethisterone acetate or d-noregestrel].
    Büttner HH; Göretzlehner G; Rudolf K
    Zentralbl Gynakol; 1976; 98(15):914-8. PubMed ID: 970000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.